Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Aceman Pharma Oy
OY
Active
Y-tunnus 2905039-4
Lautatarhankatu 6-407
Muu luonnontieteellinen ja tekninen tutkimus ja kehitt. · NACE 72190
Est. 2018
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
EUR 32K
EBITDA margin
-128.7%
Equity ratio
57.8%
Financial strength
Net profit 2019
EUR -54K
2 employees
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
Key figures
Annual report 2019
Revenue
EUR 32K
—
EBITDA
EUR -41K
—
Net profit
EUR -54K
—
Total assets
EUR 94K
—
Equity
EUR 54K
—
Employees
2
—
Company information
Legal name
Aceman Pharma Oy
Y-tunnus number
2905039-4
Legal form
Osakeyhtiö
NACE code
72190 · Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
Founded
22. maaliskuuta 2018
Share capital
—
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Contact
Address
Lautatarhankatu 6-407
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
Companies in Turku
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2019
Income statement
EUR thousands
Item
2019
Revenue
32
Staff expenses
−53
EBITDA
−41
Depreciation & amort.
−11
EBIT
−51
Net financials
−3
Profit before tax
−54
Tax
−0
Net profit
−54
Balance sheet
EUR thousands
Item
2019
Total assets
94
Equity
54
Long-term debt
34
Short-term debt
6
Total debt
40
Financial ratios
5-year trend
EBITDA margin
-128.7%
This company
15.8%
Market median
-915% vs market
2019
2019
Equity ratio
57.8%
This company
38.2%
Market median
+51% vs market
2019
2019
Return on equity
-100.0%
This company
18.4%
Market median
-643% vs market
2019
2019
Net profit margin
-172.0%
This company
8.1%
Market median
-2223% vs market
2019
2019
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
2019
2019
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
2019
2019
Annual reports & filings
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (3)
TT
Tero Tapani Weckroth
Liquidator
Liquidator
2020 – 2023
PK
Paavo Kustaa Johannes Savolainen
Chief Executive Officer
Chief Executive Officer
2018 – 2020
TJ
Turo Juhani Koila
Audit
Audit
2018 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
RP
Reko Pekko Leino
Board of Directors
2018 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Aceman Pharma Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Tero Tapani Weckroth
Liquidator
0 companies
Paavo Kustaa Johannes Savolainen
Chief Executive Officer
0 companies
Turo Juhani Koila
Audit
0 companies
Reko Pekko Leino
Board of Directors
0 companies